Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN65,1165,142,13
Msft-0,17
Nokia3,29053,2965-1,02
IBM0,08
Mercedes-Benz Group AG73,8573,870,39
PFE-0,11
29.03.2024 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 28.03.2024
Smith & Nephew (SNNUF.PK, US Other OTC (Pink Sheets))
Závěr k 28.3.2024 Změna (%) Změna (USD) Objem obchodů (ks)
12,31 -3,15 -0,40 215
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiSmith & Nephew plc
TickerSN.
Kmenové akcie:Ordinary Shares
Kmenové akcie:Ordinary Shares
RICSN.L
ISINGB0009223206
Prioritní akcie5% Preference Shares
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 18 452
Akcie v oběhu k 29.02.2024 874 320 227
MěnaUSD
Kontaktní informace
UliceBuilding 5, Croxley Park, Hatters Lane
MěstoWATFORD
PSČWD18 8YE
ZeměUnited Kingdom
Kontatní osoba 
Funkce kontaktní osoby 
Telefon442 074 017 646
Fax442079303353

Business Summary: Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Smith & Nephew plc revenues increased 6% to $5.55B. Net income increased 18% to $263M. Revenues reflect Sports Medicine & ENT segment increase of 9% to $1.73B, Orthopaedics segment increase of 5% to $2.21B, Advanced Wound Management segment increase of 6% to $1.61B, United States of America segment increase of 8% to $2.98B, Other Established Markets segment increase of 14% to $1.14B.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Devices & Implants
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSOffices of Other Holding Companies
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Offices of Other Holding Companies
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Offices of Other Holding Companies
SICSurgical Appliances And Supplies
SICSurgical Appliances And Supplies
SICElectromedical Equipment
SICSurgical And Medical Instruments
SICHolding Companies, Nec



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorDeepak Nath-01.04.202201.04.2022
Chief Financial Officer, Executive DirectorAnne-Francoise Nesmes5203.08.202003.08.2020
Chief Financial Officer - DesignateJohn Rogers-01.12.202301.12.2023
President - Global OperationsPaul Connolly-
President - OrthopaedicsCraig Gaffin-04.03.202404.03.2024
President - Advanced Wound Management and Global Commercial OperationsRohit Kashyap5301.01.2023
President - Research and DevelopmentVasant Padmanabhan-
President - Sports MedicineScott Schaffner5401.01.2023
Chief Human Resource OfficerElga Lohler-
Chief Compliance OfficerAlison Parkes-